$-0.02
(Market cap
$120 Mln
Revenue (TTM)
$292 Mln
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-5
-
Debt to Equity
1.5
-
Book Value
$--
-
EPS
$-3.7
-
Face value
--
-
Shares outstanding
75,256,381
7 Years Aggregate
CFO
$-226.93 Mln
EBITDA
$-453.20 Mln
Net Profit
$-692.89 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
| -29.1 | -23.3 | 27.4 | -47.7 | -47.5 | -50.0 | -- |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
| -66.2 | -23.5 | -12.9 | -73.2 | -9.0 | 25.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
|
1.7 | 119.7 | 292.3 | -264.8 | -84.8 | -152.8 | -- | 1.2 |
| 62.0 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 15.0 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 59.2 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 178.0 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 101.0 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 322.3 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 168.7 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 | |
| 28.9 | 12,153.4 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.9 | 2.4 |
Shareholding Pattern
View DetailsAbout Health Catalyst (HCAT)
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that... provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. Read more
-
CEO & Director
Mr. Daniel D. Burton
-
CEO & Director
Mr. Daniel D. Burton
-
Headquarters
South Jordan, UT
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Health Catalyst (HCAT)
What is the current share price of Health Catalyst Inc (HCAT) Today?
The share price of Health Catalyst Inc (HCAT) is $1.70 (NASDAQ) as of 04-Sep-2026 13:40 EDT. Health Catalyst Inc (HCAT) has given a return of -47.51% in the last 3 years.
What is the current PB & PE ratio of Health Catalyst Inc (HCAT)?
Since, TTM earnings of Health Catalyst Inc (HCAT) is negative, P/E ratio is not available.
The P/B ratio of Health Catalyst Inc (HCAT) is 1.19 times as on 28-Aug-2026, a 69 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.95 |
0.69 |
2024 |
-6.35 |
1.21 |
2023 |
-4.50 |
1.45 |
2022 |
-4.22 |
1.36 |
2021 |
-13.48 |
3.95 |
What is the 52 Week High and Low of Health Catalyst Inc (HCAT)?
The 52-week high and low of Health Catalyst Inc (HCAT) are Rs 3.62 and Rs 0.96 as of 05-Sep-2026.
What is the market cap of Health Catalyst Inc (HCAT)?
Health Catalyst Inc (HCAT) has a market capitalisation of $ 120 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Health Catalyst Inc (HCAT)?
Before investing in Health Catalyst Inc (HCAT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.